Skip to main content
. 2018 Feb 16;9:46. doi: 10.3389/fphar.2018.00046

FIGURE 4.

FIGURE 4

Analysis of metabolic pathways. (A) Summary of pathway analysis for the most relevant pathways involved under experiment conditions. (B) Tryptophan-kynurenine metabolism pathway. Dexamthesaone inhibits kenureninase which causes accumulation of kynurenine, 3-hydroxy-kenurenine, tryptophan and secondarily serotonin (5-hydroxytryptamine). Dex treatment causes significant elevation in serum levels of tyrosine (C) and hydroxyproline (D) and significant reduction in phenylalanine, lysine and arginine.